Hematology/Oncology · Pomona, CA
NPI
1619965506
Since 2005
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1910 Royalty Drive
Pomona, CA, 91767
Phone (909) 630-7290
Groups this clinician bills Medicare through
Medicare paid, 2024
$521K
28,403 services
Medicare patients, 2024
183
Average age 73
Drug cost, 2024
$3.2M
1,151 prescriptions
Company payments, 2025
$16.26
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alaa Latif was code 99214 (office e&m - established), 303 times for 107 patients. In total Alaa Latif billed 28,403 services in 53 codes, and Medicare paid $521K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 303 | 107 | $86.57 | $26K |
| 99233 Hospital E&M - Subsequent | Facility | 264 | 53 | $92.16 | $24K |
| 99215 Office E&M - Established | Office | 172 | 70 | $137.95 | $24K |
| 99223 Hospital E&M - Initial | Facility | 57 | 52 | $129.07 | $7,357 |
| 96365 Intravenous Infusion, Hydration | Office | 52 | 12 | $51.34 | $2,670 |
| 99443 Telephone Services | Office | 17 | 11 | $91.62 | $1,557 |
| 99205 Office E&M - New | Office | 13 | 13 | $167.32 | $2,175 |
By year: 2022 $775K for 45,619 services; 2023 $794K for 28,769 services; 2024 $521K for 28,403 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alaa Latif prescribed most often to Medicare patients was Anastrozole, with 133 prescriptions and refills. In total Alaa Latif wrote 1,151 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 133 | 289 | 35 | $2,005 |
| Hydroxyurea Generic | 87 | 138 | 14 | $1,016 |
| Folic Acid Generic | 75 | 130 | 15 | $342 |
| Warfarin Sodium Generic | 55 | 60 | Under 11 | $365 |
| Dexamethasone Generic | 50 | 50 | Under 11 | $804 |
| Eliquis Apixaban | 40 | 44 | Under 11 | $27K |
| Dexamethasone Sodium Phosphate Generic | 29 | 30 | 11 | $77.13 |
| Revlimid Lenalidomide | 28 | 28 | Under 11 | $470K |
| Ondansetron Hcl Ondansetron Hcl/Pf | 25 | 26 | 11 | $53.7 |
| Xarelto Rivaroxaban | 25 | 45 | Under 11 | $27K |
| Lenalidomide Generic | 25 | 25 | Under 11 | $323K |
| Acyclovir Generic | 21 | 33 | Under 11 | $334 |
| Ondansetron Odt Ondansetron | 21 | 21 | Under 11 | $260 |
| Darzalex Daratumumab | 20 | 20 | Under 11 | $146K |
| Fluoxetine Hcl Generic | 19 | 19 | Under 11 | $5.4 |
Brand drugs: 310 claims; generic drugs: 841 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alaa Latif $16.26 ($16.26 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $16.26.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $16.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.